Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion type Assertion NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_head.
- NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion description "[SEL1L immunoreactivity can be detected both in the cytoplasm and less commonly in the nuclei; the subcellular location correlates with tumor histotype, with cytoplasmic immunoreactivity being most prevalent in squamous cell carcinomas (P = .0005) and nuclear immunoreactivity being associated with adenocarcinomas (P = .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_provenance.
- NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion evidence source_evidence_literature NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_provenance.
- NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion SIO_000772 16647946 NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_provenance.
- NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion wasDerivedFrom befree-20140225 NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_provenance.
- NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_assertion wasGeneratedBy ECO_0000203 NP527115.RALtPEks3unCzJXEbo87JKr3Gkgf-wMvT1JwZ10ySBl0o130_provenance.